๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

โœ Scribed by Dennis M Black; Steven R Cummings; David B Karpf; Jane A Cauley; Desmond E Thompson; Michael C Nevitt; Douglas C Bauer; Harry K Genant; William L Haskell; Robert Marcus; Susan M Ott; James C Torner; Sara A Quandt; Theodore F Reiss; Kristine E Ensrud


Book ID
118560255
Publisher
The Lancet
Year
1996
Tongue
English
Weight
57 KB
Volume
348
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Risk of hip fracture in women with verte
โœ Mark A. Kotowicz; Dr. L. Joseph Melton III; Cyrus Cooper; Elizabeth J. Atkinson; ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 673 KB
Efficacy of continued alendronate for fr
โœ Ann V Schwartz; Douglas C Bauer; Steven R Cummings; Jane A Cauley; Kristine E En ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 102 KB

## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu